Skip to main content

Table 11 Frequency of clinical monitoring. Lipid markers

From: A propensity score matching analysis for cardio metabolic risk of antipsychotics in patients with schizophrenia using Japanese claims data

Population

Frequency of lipid marker monitoring (times/month)a

P-value

N

Mean

SD

Eligible patients

3464

0.078

0.184

Primary analysis population (PS matched)

 With atypical antipsychotic

185

0.051

0.123

0.080

 Without atypical antipsychotic

185

0.076

0.147

  1. PS Propensity score, SD Standard deviation
  2. aEligible patients: total months of examination/total months from index month to the last month available in claims data; Primary analysis population: total months of examination/12 months